Cutaneous side effects of TNF-alpha inhibitors. - Wikidata - wikimedia - TriplyDB

Cutaneous side effects of TNF-alpha inhibitors.

Cutaneous side effects of TNF-alpha inhibitors.

http://www.wikidata.org/entity/Q38933554

about

Cutaneous side effects of TNF-alpha inhibitors.

http://www.wikidata.org/entity/Q38933554

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cutaneous side effects of TNF-alpha inhibitors.

@en

type

label

Cutaneous side effects of TNF-alpha inhibitors.

@en

prefLabel

Cutaneous side effects of TNF-alpha inhibitors.

@en

P1433

Q38933554-D3796000-611D-4C4C-B80B-E5576604A1C6

P1476

Q38933554-49F3829D-A008-49CB-9352-673635E64F55

P2093

Q38933554-ABFC3A21-AF37-4881-95A4-47EB79A4D581

Q38933554-B894DB85-B73C-4B0B-B758-02ED6AAA9470

Q38933554-EC8A035A-F574-4F99-A6F7-D326D7B8EB90

P2860

Q38933554-08407D47-357F-414F-98E5-43EBEE18250C

Q38933554-09A7344B-9F6A-4176-B6FB-6B046CBEB31D

Q38933554-0B7BA893-C73F-4B23-81EF-B17677E8BB9D

Q38933554-0C530BCE-3BDB-4B01-9DC1-F41AE46CA295

Q38933554-180C2D20-21B5-4891-B6D4-097FBB65F519

Q38933554-1AC99B9D-CE0C-4526-950A-E6DE03EB4F7C

Q38933554-1FF26AC4-DC89-406C-88C0-983B8E38F07D

Q38933554-49721F9E-B4CE-4196-99D6-C64B083A2A4E

Q38933554-65A46466-088F-4325-B98E-5A8C167540D7

Q38933554-698A52FE-1550-4E52-93FF-207410CFFC5C

P304

Q38933554-7EAE5191-1127-417F-B8F5-C34644764EC1

P31

Q38933554-296A07D3-4B71-4746-9D44-663817B0B8B0

P356

Q38933554-148FB9D6-C355-4654-A940-45AB0074722D

P433

Q38933554-5FE7E493-E879-47E5-8F8B-0D76A9BE2F33

P478

Q38933554-E11A96D8-1FE9-4D8F-8576-D7DA69CF35AD

P577

Q38933554-5CF7233A-97C3-4376-936E-146B575FFA37

P698

Q38933554-7937C2F3-8223-463B-BF10-0452877285E5

P921

Q38933554-02D01C39-91EF-4C51-8D8E-A9EED25C061A

P356

P1433

P1476

Cutaneous side effects of TNF-alpha inhibitors.

@en

P2093

Claudia Lindhaus

http://www.w3.org/2001/XMLSchema#string

Jörg Tittelbach

http://www.w3.org/2001/XMLSchema#string

Peter Elsner

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data.

Use of biologic agents in combination with other therapies for the treatment of psoriasis

Erythema multiforme major following treatment with infliximab

Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis C

Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

Dermatological complications and safety of anti-TNF treatments.

T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.

Development of cutaneous sarcoidosis during treatment with tumour necrosis alpha factor antagonists.

Overview of safety of non-biologic and biologic DMARDs.

Rapid downregulation of innate immune cells, interleukin-12 and interleukin-23 in generalized pustular psoriasis with infliximab in combination with acitretin.

P304

281-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DDG.13200

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28252861

http://www.w3.org/2001/XMLSchema#string

P921